Identifying early indicators of secondary peritonitis in critically ill patients with cirrhosis.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
26 10 2021
Historique:
received: 07 07 2021
accepted: 08 10 2021
entrez: 27 10 2021
pubmed: 28 10 2021
medline: 1 2 2022
Statut: epublish

Résumé

Ascitic fluid infection (AFI) is a life-threatening complication of cirrhosis. We aimed to identify early indicators of secondary peritonitis (SP), which requires emergency surgery, and to describe the outcomes of SP and spontaneous bacterial/fungal peritonitis (SBFP). Adults with cirrhosis and AFI admitted to 16 university or university-affiliated ICUs in France between 2002 and 2017 were studied retrospectively. Cases were identified by searching the hospital databases for relevant ICD-10 codes and hospital charts for AFI. Logistic multivariate regression was performed to identify factors associated with SP. Secondary outcomes were short- and long-term mortality and survivors' functional outcomes. Of 178 included patients (137 men and 41 women; mean age, 58 ± 11 years), 21 (11.8%) had SP, confirmed by surgery in 16 cases and by abdominal computed tomography in 5 cases. Time to diagnosis exceeded 24 h in 7/21 patients with SP. By multivariate analysis, factors independently associated with SP were ascitic leukocyte count > 10,000/mm

Identifiants

pubmed: 34702902
doi: 10.1038/s41598-021-00629-4
pii: 10.1038/s41598-021-00629-4
pmc: PMC8548403
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

21076

Informations de copyright

© 2021. The Author(s).

Références

Crit Care Med. 1992 Jun;20(6):746-50
pubmed: 1597026
Best Pract Res Clin Gastroenterol. 2004 Apr;18(2):353-72
pubmed: 15123075
Gastroenterology. 1990 Jan;98(1):127-33
pubmed: 2293571
Hepatology. 1984 May-Jun;4(3):447-50
pubmed: 6724512
J Hepatol. 2006 Jan;44(1):217-31
pubmed: 16298014
Eur J Gastroenterol Hepatol. 2017 Sep;29(9):1010-1016
pubmed: 28614081
Infect Immun. 1979 Feb;23(2):403-11
pubmed: 154474
Crit Care Med. 2010 Nov;38(11):2108-16
pubmed: 20802324
Clin Gastroenterol Hepatol. 2020 Nov;18(12):2650-2666
pubmed: 31401364
J Hepatol. 2010 Jan;52(1):39-44
pubmed: 19897273
Gut. 2006 Oct;55 Suppl 6:vi1-12
pubmed: 16966752
J Hepatol. 2000 Jan;32(1):142-53
pubmed: 10673079
Ann Intensive Care. 2017 Dec;7(1):33
pubmed: 28321803
Scand J Gastroenterol. 2016 Jan;51(1):121-8
pubmed: 26153059
Lancet. 1974 Jul 13;2(7872):81-4
pubmed: 4136544
Gastroenterology. 2007 Apr;132(4):1261-9
pubmed: 17408652
Crit Care Med. 2018 May;46(5):705-712
pubmed: 29309369
Stat Med. 2006 Dec 30;25(24):4216-26
pubmed: 16955543
Aliment Pharmacol Ther. 2015 Jun;41(11):1116-31
pubmed: 25819304
Br J Surg. 1973 Aug;60(8):646-9
pubmed: 4541913
J Hepatol. 2001 Feb;34(2):215-21
pubmed: 11281549
J Crit Care. 2016 Dec;36:234-239
pubmed: 27569253
N Engl J Med. 2004 Apr 15;350(16):1646-54
pubmed: 15084697
JAMA. 1993 Dec 22-29;270(24):2957-63
pubmed: 8254858
Eur J Gastroenterol Hepatol. 2012 Aug;24(8):897-904
pubmed: 22569082

Auteurs

Carole Ruault (C)

Medical-Surgical Intensive Care Unit, Versailles Hospital, 177 rue de Versailles, 78150, Le Chesnay Cedex, France.

Nathalie Zappella (N)

Anesthesiology and Critical Care Medicine Departement, DMU PARABOL, Bichat-Claude Bernard Hospital, HUPNVS, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.

Julien Labreuche (J)

Centre Hospitalier Régional et Universitaire de Lille, ULR 2694 - METRICS: Évaluation des Technologies de Santé et des Pratiques Médicales, 59000, Lille, France.

Pierrick Cronier (P)

Intensive Care Unit, Sud-Francilien Hospital Center, 91100, Corbeil-Essonnes, France.

Baptiste Claude (B)

Department of Intensive Care, University Hospital François Mitterrand, 21000, Dijon, France.

Marc Garnier (M)

Department of Anesthesiology and Critical Care Medicine, Sorbonne University, GRC 29, Assistance Publique-Hôpitaux de Paris (AP-HP), DMU DREAM, Tenon University Hospital, 75020, Paris, France.

Antoine Vieillard-Baron (A)

Medical-Surgical Intensive Care Unit, Ambroise Paré University Hospital, APHP, 92100, Boulogne-Billancourt, France.

Sofia Ortuno (S)

Medical Intensive Care Unit, Georges Pompidou European Hospital, Assistance Publique-Hôpitaux de Paris, 75015, Paris, France.

Maxime Mallet (M)

Groupe Hospitalier Universitaire APHP-Sorbonne Université, Site Pitié-Salpêtrière, Service de Pneumologie, Médecine Intensive et Réanimation (Département R3S), 75013, Paris, France.

Olga Cosic (O)

Medical-Surgical Intensive Care Unit, Hôpital Nord Franche-Comté, 90400, Trevenans, France.

Laura Crosby (L)

Intensive Care Unit, University Hospital of Pointe-à-Pitre, 97159, Pointe-à-Pitre, Guadeloupe, France.
Intensive Care Unit, Centre Hospitalier de Valence, 179 Boulevard Maréchal Juin, 26000, Valence, France.

Olivier Lesieur (O)

Intensive Care Unit, Groupement Hospitalier La Rochelle Ré Aunis, 17000, La Rochelle, France.

Nicolas Pichon (N)

Medical-Surgical Intensive Care Unit, Limoges University Hospital, 87000, Limoges, France.

Arnaud Galbois (A)

Ramsay-Générale de Santé, Hôpital Privé Claude Galien, Service de Réanimation Polyvalente, 91480, Quincy-sous-Sénart, France.

Cedric Bruel (C)

Medical and Surgical Intensive Care Unit, Groupe Hospitalier Paris Saint Joseph, 75014, Paris, France.

Kenneth Ekpe (K)

Medical Intensive Care Unit, Saint Louis Teaching Hospital, Assistance Publique Hôpitaux de Paris, 75010, Paris, France.

Bertrand Sauneuf (B)

General Intensive Care Unit, Cotentin Public Hospital Center, 50100, Cherbourg-en-Cotentin, France.

Damien Roux (D)

Department of Intensive Care, Louis Mourier University Hospital, Assistance Publique-Hôpitaux de Paris, 92700, Colombes, France.

Stephane Legriel (S)

Medical-Surgical Intensive Care Unit, Versailles Hospital, 177 rue de Versailles, 78150, Le Chesnay Cedex, France. slegriel@ch-versailles.fr.
Université Paris-Saclay, UVSQ, CESP, Team DevPsy, 94807, Villejuif, Inserm, France. slegriel@ch-versailles.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH